Dianthus Therapeutics, Inc. /DE/
Disclosed SEC business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Dianthus Therapeutics, Inc. /DE/ (ticker DNTH, CIK 0001690585) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
You've reached this month's free company deep views
The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.
Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-24T19:20:43.813072+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-02T10:47:31.273594+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-02T10:47:35.565531+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-02T10:47:29.142455+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.